We serve Chemical Name:(S)-Boc-3-Methoxy-β-Phe-OH CAS:499995-77-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(S)-Boc-3-Methoxy-β-Phe-OH
CAS.NO:499995-77-6
Synonyms:Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-3-methoxy-, (βS)-;3-(3-Methoxyphenyl)-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)propanoic acid;Boc-3-Methoxy-L-b-phenylalanine;(3S)-3-(3-Methoxyphenyl)-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)propanoic acid;3-[(tert-Butoxycarbonyl)amino]-3-(3-methoxyphenyl)propanoic acid;Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-3-methoxy-;Boc-β-Phe(3-OMe)-OH;Boc-(S)-3-Amino-3-(3-methoxyphenyl)-propionic acid;N-Boc-L-3-Amino-3-(3-methoxylphenyl)propanoic acid;(S)-Boc-3-Methoxy-β-Phe-OH
Molecular Formula:C15H21NO5
Molecular Weight:295.331
HS Code:2924299090
Physical and Chemical Properties:
Melting point:81-83°C
Boiling point:458.5±45.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.522
PSA:84.86000
Exact Mass:295.141968
LogP:2.63
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-3-methoxy-, (βS)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-Boc-3-Methoxy-β-Phe-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boc-3-Methoxy-L-b-phenylalanine Use and application,3-[(tert-Butoxycarbonyl)amino]-3-(3-methoxyphenyl)propanoic acid technical grade,usp/ep/jp grade.
Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. (S)-Boc-3-Methoxy-β-Phe-OH manufacturer The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. (S)-Boc-3-Methoxy-β-Phe-OH supplier But even though weight-loss success depends on adopting a challenging” change in post-operation diet and lifestyle, the process can certainly “help people to lose weight and get comorbid [other negative health] conditions under better control,” Sandon said.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies. (S)-Boc-3-Methoxy-β-Phe-OH vendor The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. (S)-Boc-3-Methoxy-β-Phe-OH factory It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies. (S)-Boc-3-Methoxy-β-Phe-OH vendor The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients. (S)-Boc-3-Methoxy-β-Phe-OH factory It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.
